London Markets: Moderna and SpaceX highlighted by a fast-growing U.S. fund traded in LondonCurrent / By admin Baillie Gifford U.S. Growth Trust devoted much of its half-yearly report to talking up the prospects of biotech Moderna and rocket launcher SpaceX, two of its investments that helped lift its net asset value surge during the time frame. Facebook Twitter Google+ Email Tumblr LinkedIn Pinterest WhatsApp Messenger Reddit